114 results
8-K
EX-99.1
CUE
Cue Biopharma Inc
9 May 24
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:01pm
, we are led by an experienced management team and independent Board of Directors with deep expertise in immunology and immuno-oncology as well
DEFA14A
CUE
Cue Biopharma Inc
26 Apr 24
Additional proxy soliciting materials
3:46pm
of the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31,
3. The approval, on a non
S-8
EX-23.2
CUE
Cue Biopharma Inc
28 Mar 24
Registration of securities for employees
4:29pm
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement
S-8
ltrexz z9m0y0gkilljb
28 Mar 24
Registration of securities for employees
4:29pm
8-K
codp0lc6
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:31pm
DEFA14A
zm0o9qn1gozbp0bv4
28 Apr 23
Additional proxy soliciting materials
4:07pm
424B3
jgtomxdtnug2drn
15 Dec 22
Prospectus supplement
4:42pm